A phase III trial of GEN-003 for genital herpes

Trial Profile

A phase III trial of GEN-003 for genital herpes

Planning
Phase of Trial: Phase III

Latest Information Update: 20 Feb 2017

At a glance

  • Drugs GEN 003 (Primary)
  • Indications Herpes genitalis
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Feb 2017 Planned initiation date changed to 1 Oct 2017.
    • 05 Jan 2017 According to a Genocea Biosciences media release, the company anticipates to initiate this study in the fourth quarter of 2017.
    • 03 Nov 2016 According to a Genocea Biosciences media release, this study is expected to begin in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top